The financial playbook for medical spa owners.
Injectable margins, device ROI, deferred revenue, MSO/PC structure, and the weekly numbers that tell you whether your practice is actually profitable, written specifically for med spas, not generic small businesses.
A well-run single-location medical spa should produce 27.6% EBITDA at $1.5 million in annual revenue, according to AMSPA data. Most practices run 8 to 14 points below this because injectable product costs, device lease payments, and labor drift are never tracked against revenue on a weekly basis.
Read the full analysisLabor above 42% of revenue is the warning line. Above 50%, the practice loses money on growth. How to calculate it and what to do when the number starts drifting.
Recording package sales as revenue on collection overstates monthly profit by thousands. Most med spa books never use deferred revenue. Here is the correct setup.
Your real injectable margin is 60-70% after vendor COGS, not the 80%+ QuickBooks shows. Step-by-step calculation with a worked Botox example and per-treatment breakdown.
Allergan invoices sit in email. QBO shows 80 to 90 percent injectable margin. The real number is 60 to 70. Six-step reconciliation with a worked Botox example.
AbbVie's Botox revenue fell 4.1% in 2025 while Galderma's neuromodulator line grew 14.3%. What that split means for your injectable COGS and how to reconcile vendor invoices against POS revenue.
The average med spa runs at 47% staff utilization. Top earners run at 78%. The revenue gap between those two numbers at a typical practice is over $2 million per year.
Membership sales grew 24% in 2024. Most med spas book it as revenue when collected. That is wrong. The correct treatment uses deferred revenue, and this post shows the journal entries.
The BLS puts nurse practitioner mean wages at $132,050 annually and licensed estheticians at $19.98 per hour. Here is how those figures translate to a med spa P&L and where most practices overpay.
Zenoti data from 30,000+ businesses puts average med spa revenue at $1,035,229. Top earners reach $3,219,354. The P&L structure at each tier is completely different.
Juvederm revenue fell 15.3% in 2025 while Galderma's filler segment grew 8%. If your practice is switching product lines, your COGS accounting needs to change at the same time.
The 2026 Section 179 limit is $2,560,000 per Rev. Proc. 2025-32, and bonus depreciation is back to 100% under the One Big Beautiful Bill Act. Here is how to apply both to med spa equipment purchases.
Medspas have the highest no-show rate of any beauty category at 5%, plus a 16% cancellation rate. At average ticket sizes, that adds up to over $17,000 in monthly revenue leakage for a typical practice.
The medical spa market is projected to reach $26.2 billion by 2030, but 81% of practices are single-location owner-operators with no fractional CFO and no weekly P&L. That is the gap Spa Ledger fills.
Average revenue $1.04M to $1.39M. Profit margins at 38%. Labor target 35-42%. Injectable COGS 30-40%. All the benchmarks a med spa owner and CFO need, sourced and cited.
The default QuickBooks chart of accounts has no line for injectable product expense, no device lease account, and no structure for MSO/PC separation. Here is the correct setup.
Break-even formula, Section 179 treatment, and utilization benchmarks for med spa laser and body contouring devices. The calculation most owners have never run.
Target 27-38% EBITDA at $1-1.5M revenue. Most practices run 10-15 points below that. The four line items that explain the gap: labor, injectable COGS, device leases, owner comp.
A bookkeeper closes the books. A fractional CFO tracks injectable COGS weekly, flags labor drift, and tells you whether your device lease is generating a return. Most med spas have neither.
An MSO/PC structure requires two separate QuickBooks files and an intercompany management fee. Running both entities through one P&L is the most common compliance gap in med spa finance.
Buyers underwrite on three years of normalized EBITDA. Deferred revenue misstatements, commingled MSO/PC books, and above-market owner comp are the three items most likely to reduce your valuation.
Five metrics every week: revenue by service line, labor percentage against 35-42%, injectable COGS reconciled against vendor invoices, device utilization, and rebooking rate vs. the 40% benchmark.
An NP at $132,050 base needs to generate roughly $434,000 in annual revenue at a 40% COGS load to clear a 25% contribution margin. Most med spas have never run this number by provider.
Zenoti and Boulevard record transactions. They do not allocate COGS, recognize deferred revenue, or produce a balance sheet. Five things your POS skips and what QuickBooks needs to handle instead.
Base salary plus commission above a threshold outperforms straight commission at 3 of 4 revenue tiers. The net-of-consumables formula, the compliance risk, and the revenue level where each model makes sense.
Most med spas expense Allergan and Galderma invoices to a generic supplies account. That hides your real injectable margin. Here is the 6-step fix and the chart of accounts structure that makes it permanent.